This resulted in a higher proportion of CD patients in remission than before dose escalation ( @ % vs @ % ; P = @ ) and a decrease in the median concentration of C-reactive protein , compared with before the dose increase ( @ vs @ mg/L ; P < @ ) ; these changes were not observed in patients with UC .